Company / Income Tax
NovaBay Pharmaceuticals, Inc. Income Tax History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-
FY2024
5-year range
$0 / $5.0K
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#119 of 202
Health Care
What the data says
Remained stable around $0 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#84 of 202 in Health CareTop 41% of 202
▼
Key checks
Key Insights
- Peak income tax was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0 | - |
| FY2023 | $0 | - |
| FY2022 | $0 | - |
| FY2021 | $0 | -100.0% |
| FY2020 | $5.0K | -16.7% |
| FY2019 | $6.0K | +50.0% |
| FY2018 | $4.0K | +33.3% |
| FY2017 | $3.0K | +50.0% |
| FY2016 | $2.0K | +0.0% |
| FY2015 | $2.0K | +0.0% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026